Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Solomon Habtemariam and Maciej Banach.
Solomon Habtemariam
Connection Strength
0.669
Maciej Banach
  1. Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! J Cell Mol Med. 2020 09; 24(17):10267-10269.
    View in: PubMed
    Score: 0.223
  2. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy? Arch Med Res. 2020 10; 51(7):733-735.
    View in: PubMed
    Score: 0.221
  3. Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell. Clin Transl Sci. 2021 03; 14(2):431-433.
    View in: PubMed
    Score: 0.058
  4. Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do? Clin Biochem. 2020 Dec; 86:31-33.
    View in: PubMed
    Score: 0.056
  5. Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? Biochimie. 2020 Oct; 177:50-52.
    View in: PubMed
    Score: 0.056
  6. Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2. Arch Med Sci. 2020; 16(3):519-521.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.